- Home
- Companies
- AVROBIO, Inc.
- Products
- AVROBIO - Model AVR-RD-04 - Gene ...
AVROBIO - Model AVR-RD-04 - Gene Therapy for Cystinosis
AVROBIO’s investigational gene therapy for cystinosis is being studied in a Phase 1/2 investigational trial sponsored by the University of California, San Diego. The first patient was dosed in October 2019. The single-arm trial is expected to enroll four adults and a potential follow-on cohort of two adults or adolescents at least 14 years of age who are currently being treated with cysteamine, the standard of care for cystinosis.
-
Most popular related searches
Customer reviews
No reviews were found for AVROBIO - Model AVR-RD-04 - Gene Therapy for Cystinosis. Be the first to review!